Daunorubicin is an anthracycline antibiotic mainly used to treat various types of cancers, especially leukemias. It can be used to treat both acute and chronic leukemias. This activity will summarize the mechanism of action, adverse event profile, and other key factors (e.g., indications, contraindications, pharmacodynamics, pharmacokinetics, monitoring, relevant interaction) pertinent to daunorubicin therapy well as important prescribing and management consideration by the healthcare team.

**Objectives:**
- Identify the mechanism of action and administration of daunorubicin. 
- Describe the potential adverse effects of daunorubicin. 
- Outline the appropriate monitoring necessary for patients receiving daunorubicin. 
- Review interprofessional team strategies for improving care coordination communication to advance daunorubicin therapy and improve outcomes.